Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  CEL-SCI Corporation    

 SummaryNewsCalendarCompanyFinancials 
Company
CEL-SCI Corp. is a biotechnology company, which is involved in the research and development of investigational immunotherapy products for the treatment of cancer and infectious diseases.The company's lead investigational therapy, Multikine is currently in a pivotal phase 3 clinical trial against... 
More about the company
Latest news on CEL-SCI CORPORATION
12/02 CEL SCI CORP : Entry into a Material Definitive Agreement (form 8-K)
12/02 CEL-SCI CORPORATION (NASDAQ : CSCIW) Files An 8-K Entry into a Material Definiti..
12/02 CEL SCI : NEW STORY CEL-SCI Announces Pricing of $4.25 Million Public Offering o..
12/02 CEL SCI : Announces Pricing of $4.25 Million Public Offering of Common Stock and..
12/01 CEL SCI : NEW STORY CEL-SCI Announces Proposed Public Offering of Common Stock a..
12/01 CEL SCI : Announces Proposed Public Offering of Common Stock and Warrants
12/01 CEL SCI : Submits Response to FDA in Connection with Partial Clinical Hold on Ph..
11/22 CEL SCI : Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treati..
11/21 CEL SCI : NEW STORY CEL-SCI Submits Response to FDA in Connection with Partial C..
11/14 CEL SCI : NEW STORY CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine Is Su..
More news
Sector news : Bio Therapeutic Drugs
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Geert R. Kersten CEO, CFO, Treasurer, Director & CAO
Patricia B. Prichep Secretary & Senior Vice President-Operations
Eyal Talor Chief Scientific Officer
Alexander G. Esterhazy Independent Director
Peter R. Young Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CEL-SCI CORPORATION23
AMGEN, INC.-13.02%105 034
GILEAD SCIENCES, INC.-28.08%95 884
CELGENE CORPORATION-5.93%87 334
REGENERON PHARMACEUTIC..-33.32%38 181
ACTELION LTD45.20%22 191
More Results